S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

ZoomInfo Investors Face August 24 Deadline in Securities Fraud Lawsuit

Investors who incurred financial losses from ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, have until August 24 to apply as lead plaintiffs in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company's growth trajectory and AI-driven business performance.

ZoomInfo Investors Face August 24 Deadline in Securities Fraud Lawsuit
Photo: Bio & News

The complaint, filed by the law firm Glancy Prongay Wolke & Rotter LLP, contends that ZoomInfo executives provided misleading projections that obscured significant operational headwinds. Specifically, the suit alleges that management failed to disclose a cooling demand for seat-based licenses and a weakening appetite for the firm's AI-integrated go-to-market solutions. These undisclosed factors, according to the filing, rendered the company’s 2026 revenue guidance unattainable and lacked a reasonable basis.

Those who purchased shares during the specified period are not required to take immediate action to remain part of the potential class, as no class has been certified yet. Investors opting to seek a more active role in the litigation must file their motions with the court by the August 24 deadline. Glancy Prongay Wolke & Rotter LLP is currently soliciting inquiries from affected shareholders via their Los Angeles office, email, or dedicated telephone lines.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!